Quoin Pharmaceuticals Ltd Stock Price on December 20, 2024
| QNRX Stock | USD 0.55 0.01 1.79% |
Below is the normalized historical share price chart for Quoin Pharmaceuticals Ltd extending back to July 29, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Quoin Pharmaceuticals stands at 0.55, as last reported on the 29th of December, with the highest price reaching 0.60 and the lowest price hitting 0.54 during the day.
If you're considering investing in Quoin Stock, it is important to understand the factors that can impact its price. Quoin Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Quoin Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0612, which implies the firm had a 0.0612% return per unit of risk over the last 3 months. By analyzing Quoin Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please evaluate Quoin Pharmaceuticals' Coefficient Of Variation of 2159.84, semi deviation of 5.47, and Risk Adjusted Performance of 0.0461 to confirm if our risk estimates are consistent with your expectations.
Total Stockholder Equity is likely to rise to about 6.6 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 855.9 K in 2024. . Price Earnings To Growth Ratio is likely to rise to 0.02 in 2024, whereas Price To Sales Ratio is likely to drop (45.87) in 2024. Quoin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of July 2016 | 200 Day MA 0.6735 | 50 Day MA 0.6869 | Beta 1.886 |
Quoin |
Sharpe Ratio = 0.0612
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | QNRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.63 actual daily | 94 94% of assets are less volatile |
Expected Return
| 0.65 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Quoin Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Quoin Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.8275 | Book Value 5.737 | Enterprise Value -5.8 M | Enterprise Value Ebitda (0.42) | Shares Float 3.9 M |
Quoin Pharmaceuticals Main Headline on 20th of December 2024
Quoin Pharmaceuticals Announces Pricing of 6.8 Million Publi... by finance.yahoo.com
ASHBURN, Va., Dec. 20, 2024 -- Quoin Pharmaceuticals Ltd. , a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announced the pricing of its reasonable best efforts public offering of 15,111,110 ordinary shares represented by 15,111,110 American Depositary Shares , Series F warrants to purchase an aggregate of up to 15,111,110 ordinary shares repr
Quoin Pharmaceuticals Valuation on December 20, 2024
It is possible to determine the worth of Quoin Pharmaceuticals on a given historical date. On December 20, 2024 Quoin was worth 0.43 at the beginning of the trading date compared to the closed value of 0.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Quoin Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Quoin Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Quoin Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Quoin Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.64 | 0.68 | 0.54 | 0.65 | 10,887,890 | |
12/20/2024 | 0.43 | 0.63 | 0.43 | 0.57 | 2,219,418 |
| 0.55 | 0.56 | 0.50 | 0.52 | 268,007 |
| Backtest Quoin Pharmaceuticals | | | Quoin Pharmaceuticals History | | | Quoin Pharmaceuticals Valuation | Previous | Next |
Quoin Pharmaceuticals Trading Date Momentum on December 20, 2024
| On December 23 2024 Quoin Pharmaceuticals Ltd was traded for 0.52 at the closing time. The top price for the day was 0.56 and the lowest listed price was 0.50 . The trading volume for the day was 268 K. The trading history from December 23, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 8.77% . The trading delta at closing time against the current closing price is 5.26% . |
Quoin Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Quoin Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Quoin Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Quoin financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Quoin Pharmaceuticals Stock history
Quoin Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Quoin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Quoin Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Quoin Pharmaceuticals stock prices may prove useful in developing a viable investing in Quoin Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 900.9 K | 855.9 K | |
| Net Loss | -8.5 M | -8.9 M |
Quoin Pharmaceuticals Stock Technical Analysis
Quoin Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Quoin Pharmaceuticals Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Quoin Pharmaceuticals Ltd cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Quoin Pharmaceuticals December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Quoin Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quoin Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Quoin Pharmaceuticals stock market strength indicators, traders can identify Quoin Pharmaceuticals Ltd entry and exit signals to maximize returns
Quoin Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Quoin Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Quoin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Quoin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0461 | |||
| Jensen Alpha | 0.4395 | |||
| Total Risk Alpha | 0.1838 | |||
| Sortino Ratio | 0.0745 | |||
| Treynor Ratio | 0.29 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.